GRAIL (GRAL) Financials: History & Chart

GRAIL Inc.(GRAL)

Medical - Diagnostics & Research · Menlo Park, CA

$139.72-14.36 (-9.32%)

Delayed quote: Oct 6, 2026, 2:00 PM EDT

About GRAIL Inc.

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

Menlo Park, CA

910 employees

www.grail.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Joshua J. Ofman

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	165.26M	44.69M	40.78M	43.60M	36.19M	35.54M	31.84M	38.25M	28.65M
Cost of Goods Sold	183.16M	57.25M	21.24M	54.73M	49.93M	53.32M	51.77M	54.22M	50.88M
Gross Profit	-17.89M	-12.57M	19.54M	-11.14M	-13.73M	-17.77M	-19.93M	-15.97M	-22.23M
Gross Profit Margin	-10.8%	-28.1%	47.9%	-25.5%	-37.9%	-50.0%	-62.6%	-41.7%	-77.6%
Total Operating Expenses	541.36M	161.22M	155.31M	113.28M	111.56M	141.08M	133.68M	120.97M	161.27M
Research & Development	190.99M	47.43M	48.02M	46.90M	48.65M	46.63M	53.63M	48.33M	78.23M
Selling, General & Administrative	291.09M	88.36M	73.44M	66.38M	62.91M	66.45M	80.05M	72.64M	83.04M
Operating Income (EBIT)	-559.25M	-173.78M	-135.76M	-124.41M	-125.29M	-158.85M	-153.61M	-136.94M	-183.51M
Operating Margin	-338.4%	-388.9%	-332.9%	-285.4%	-346.2%	-446.9%	-482.5%	-358.0%	-640.5%
Income Before Tax (EBT)	-529.47M	-166.71M	-127.52M	-116.52M	-118.72M	-152.86M	-146.41M	-126.99M	-172.41M
Interest Income	29.28M	7.23M	7.99M	7.96M	6.11M	6.81M	7.78M	9.37M	11.66M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	29.78M	7.08M	8.24M	7.89M	6.57M	6.00M	7.20M	9.94M	11.10M
Net Income	-391.59M	-110.25M	-93.19M	-99.18M	-88.98M	-113.98M	-106.21M	-97.07M	-125.69M
Income Tax Expense	-137.88M	-56.46M	-34.34M	-17.34M	-29.74M	-38.87M	-40.20M	-29.93M	-46.72M
Net Profit Margin	-236.9%	-246.7%	-228.5%	-227.5%	-245.8%	-320.7%	-333.6%	-253.8%	-438.7%
EBITDA	-403.88M	-135.09M	-96.97M	-85.50M	-86.31M	-119.68M	-114.33M	-97.50M	-144.28M
EBITDA Margin	-244.4%	-302.3%	-237.8%	-196.1%	-238.5%	-336.7%	-359.1%	-254.9%	-503.5%
Depreciation & Amortization	155.37M	38.69M	38.79M	38.91M	38.98M	39.17M	39.28M	39.44M	39.23M
EPS Basic	-9.75	-2.56	-2.29	-2.44	-2.46	-3.18	-3.10	-2.89	-3.94
EPS Diluted	-9.75	-2.56	-2.29	-2.44	-2.46	-3.18	-3.10	-2.89	-3.94
Weighted Average Basic Shares	43.11M	43.11M	40.64M	40.73M	36.12M	35.05M	34.31M	31.90M	31.88M
Weighted Average Diluted Shares	43.11M	43.11M	40.64M	40.73M	36.12M	35.05M	34.31M	31.90M	31.88M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	147.17M	125.59M	93.11M	55.55M	14.61M	0.00	0.00	0.00
Cost of Goods Sold	209.75M	203.62M	188.72M	172.00M	114.61M	0.00	0.00	0.00
Gross Profit	-62.57M	-78.02M	-95.61M	-116.45M	-100.00M	0.00	0.00	0.00
Gross Profit Margin	-42.5%	-62.1%	-102.7%	-209.6%	-684.4%	N/A	N/A	N/A
Total Operating Expenses	471.59M	2.11B	1.42B	5.33B	1.17B	316.42M	255.66M	287.50M
Research & Development	195.79M	322.38M	338.75M	329.58M	460.21M	192.91M	167.09M	223.16M
Selling, General & Administrative	275.80M	367.82M	362.56M	296.44M	234.06M	123.51M	88.58M	64.34M
Operating Income (EBIT)	-534.16M	-2.19B	-1.52B	-5.44B	-1.27B	-316.42M	-255.66M	-287.50M
Operating Margin	-363.0%	-1743.0%	-1627.6%	-9798.2%	-8659.6%	N/A	N/A	N/A
Income Before Tax (EBT)	-534.50M	-2.16B	-1.51B	-5.44B	-1.27B	-312.12M	-245.05M	-275.23M
Interest Income	28.65M	26.73M	7.95M	1.74M	332K	6.14M	12.43M	8.34M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	-341K	26.80M	7.75M	1.50M	90K	4.29M	10.61M	12.26M
Net Income	-408.35M	-2.03B	-1.47B	-5.40B	-1.25B	-312.16M	-244.85M	-275.72M
Income Tax Expense	-126.15M	-135.36M	-41.95M	-42.29M	-17.48M	33K	-195K	485K
Net Profit Margin	-277.5%	-1613.9%	-1574.2%	-9719.3%	-8539.4%	N/A	N/A	N/A
EBITDA	-377.82M	-2.03B	-1.36B	-5.29B	-1.21B	-308.85M	-245.36M	-273.42M
EBITDA Margin	-256.7%	-1617.2%	-1457.2%	-9519.6%	-8259.6%	N/A	N/A	N/A
Depreciation & Amortization	156.34M	158.06M	158.70M	154.76M	58.45M	7.56M	10.31M	14.08M
EPS Basic	-11.11	-63.54	-47.20	-173.87	-40.18	-2.52	-1.99	-2.42
EPS Diluted	-11.11	-63.54	-47.20	-173.87	-40.18	-2.52	-1.99	-2.42
Weighted Average Basic Shares	36.75M	31.90M	31.05M	31.05M	31.05M	123.67M	123.19M	114.14M
Weighted Average Diluted Shares	36.75M	31.90M	31.05M	31.05M	31.05M	123.67M	123.19M	114.14M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.